rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

DENTSPLY SIRONA Inc.

XRAY · Nasdaq

Health CareMedical DevicesNot moving yet

XRAY stood above a rising 150-day average in 4 of the last 52 weekly readings, and has been out of that trend for the last 10 weeks. It is 22.6% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 10
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$3.4M
Insider sales, 12 months
$916K
Officials’ trades on record
14
Institutions holding
350 (-7)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 4 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$809K$0$1.9MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

14 disclosed lines: House 13, Senate 1, executive 0; 8 people.

WhoDidAmountTraded
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31sold$1k–$15k8 Jan 2025filed 11 Feb 2025
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31sold$1k–$15k7 Jan 2025filed 11 Feb 2025
Lois Frankel House: U.S. House ClerkFL21sold$1k–$15k5 Dec 2021filed 16 Jan 2022
Lois Frankel House: U.S. House ClerkFL21sold$1k–$15k3 Dec 2021filed 16 Jan 2022
Lois Frankel House: U.S. House ClerkFL21bought$1k–$15k9 May 2019filed 21 May 2019
Dean Phillips House: U.S. House ClerkMN03bought$1k–$15k4 Jan 2019filed 18 Feb 2019
Lois Frankel House: U.S. House ClerkFL21bought$1k–$15k15 May 2018filed 29 May 2018
Alan S. Lowenthal House: U.S. House ClerkCA47sold$1k–$15k20 Jan 2017filed 25 Jan 2017
James B. Renacci House: U.S. House ClerkOH16sold$15k–$50k14 Nov 2016filed 17 Nov 2016
Alan S. Lowenthal House: U.S. House ClerkCA47boughtspouse$1k–$15k14 Oct 2016filed 15 Oct 2016
K. Michael Conaway House: U.S. House ClerkTX11sold$1k–$15k12 Sep 2016filed 12 Oct 2016
Thomas MacArthur House: U.S. House ClerkNJ03sold$1k–$15k27 May 2015filed 7 Jun 2015

Insiders

Buy orders, 12 months12
Sale orders, 12 months1
Buyers · sellers9 · 1
WhoDidSharesTraded
Brian T. GladdenDirectorbought9,985.022at $10.0215 Jun 2026filed 15 Jun 2026
Clyde HoseinDirectorbought6,500at $9.9915 Jun 2026filed 16 Jun 2026
Brian P. McKeonDirectorbought10,000at $10.1212 Jun 2026filed 15 Jun 2026
Jonathan Jay MazelskyDirectorbought10,000at $10.1412 Jun 2026filed 18 Jun 2026
Michael J. BarberDirectorbought15,175at $9.8911 Jun 2026filed 15 Jun 2026
Betsy D. HoldenDirectorbought10,086at $9.8811 Jun 2026filed 15 Jun 2026
James D. ForbesDirectorbought5,000at $12.489 Mar 2026filed 9 Mar 2026
Gregory T. LucierDirectorbought15,000at $12.459 Mar 2026filed 9 Mar 2026
James D. ForbesDirectorbought5,000at $13.473 Mar 2026filed 3 Mar 2026
Gregory T. LucierDirectorbought22,445at $14.033 Mar 2026filed 3 Mar 2026
Gregory T. LucierDirectorbought27,555at $14.252 Mar 2026filed 3 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders350-7 on the quarter
New · exited62 · 68
Reported value$2.4B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 202626,711,079$283.4M+7,459,210+38.7%
FULLER & THALER ASSET MANAGEMENT, INC.reduced · filed 12 Aug 202612,697,269$134.7M-95,249−0.7%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 202611,779,851$125.0M+1,249,105+11.9%
AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 202610,458,771$110.2M+6,493,548+163.8%
STATE STREET CORPadded · filed 7 Aug 20269,285,298$98.5M+2,040,461+28.2%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20269,047,628$96.0M+48,071+0.5%
LAZARD ASSET MANAGEMENT LLCadded · filed 14 Aug 20268,269,867$87.7M+1,554,104+23.1%
ARIEL INVESTMENTS, LLCadded · filed 14 Aug 20268,026,107$85.2M+1,639,292+25.7%
Southpoint Capital Advisors LPreduced · filed 14 Aug 20267,000,000$74.3M-3,000,000−30.0%
COOKE & BIELER LPreduced · filed 30 Jul 20266,927,915$73.5M-873,272−11.2%
31 Mar 2023 – 30 Jun 2026
327362396Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Jonathan Jay Mazelsky Company insiderDirector · last 30 Sep 20261 · 0
John C. Fortson Company insiderEVP & CFO · last 10 Aug 20260 · 0
Andrea L. Frohning Company insiderSVP, CHRO · last 7 Aug 20260 · 0
Brian T. Gladden Company insiderDirector · last 15 Jun 20261 · 0
Clyde Hosein Company insiderDirector · last 15 Jun 20261 · 0
Brian P. McKeon Company insiderDirector · last 12 Jun 20261 · 0
Betsy D. Holden Company insiderDirector · last 11 Jun 20262 · 0
Michael J. Barber Company insiderDirector · last 11 Jun 20261 · 0
Donald Zurbay Company insiderDirector · last 3 Jun 20260 · 0
Gregory T. Lucier Company insiderDirector · last 3 Jun 202615 · 1
James D. Forbes Company insiderDirector · last 3 Jun 20262 · 0
Janet S. Vergis Company insiderDirector · last 3 Jun 20260 · 0

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202550.0%
Operating profit marginFY 2025 · to 31 Dec 2025-11.5%
Free cash flow marginFY 2025 · to 31 Dec 20252.8%
Return on capital employedFY 2025 · to 31 Dec 2025-10.3%
Debt to equityFY 2025 · to 31 Dec 20251.87×
Research spendFY 2025 · to 31 Dec 20254.1%
Share count trendFY 2025 · to 20 Feb 20260.1%
Cash and equivalentsFY 2025 · to 31 Dec 2025$326.0M
Free cash flowFY 2025 · to 31 Dec 2025$104.0M

Analyst forecasts

No analyst forecasts yet.